ProstataJournal of Clinical Oncology · 2023
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO)
Francolini G., Allegra A.G., Detti B., et al.
Leggi su DOI ↗MammellaRadiotherapy and Oncology · 2023
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation therapy: A systematic review and meta-analysis
Salvestrini V., Kim K., Caini S., et al.
Leggi su DOI ↗ProstataLa Radiologia Medica · 2023
Pattern of recurrence after stereotactic body radiotherapy for para-aortic oligo-recurrent prostate cancer, a multicentric analysis
Francolini G., Garlatti P., Di Cataldo V., et al.
Leggi su DOI ↗ProstataMedical Oncology · 2023
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients
Francolini G., Porreca A., Facchini G., et al.
Leggi su DOI ↗